ELUTE fiber provides pharmaceutical, therapeutic, and medical device companies with cutting-edge biodegradable polymers for implantable drug delivery.

TissueGen’s patented extrusion process enables delivery of the broadest range of temperature-sensitive pharmaceuticals and biologics previously impossible to incorporate in implantable devices. In more ways than ever, medical device developers can now deploy advanced drug delivery with ELUTE® fiber – an incredible breakthrough that drastically expands the drugs deliverable via implantable fibers.

LEARN MORE
fiber-updatednew0

ELUTE® Fiber

ELUTE® FIBER APPLICATIONS

TissueGen’s ELUTE fiber is ideally suited for a broad range of clinical applications and enables drug delivery from implantable devices for many therapeutic indications.

Advanced Drug Delivery

new-drug-delivery

TissueGen’s patented room temperature fiber extrusion technology  preserves the biological activity of incorporated drugs and enables an entirely new format for drug delivery via biodegradable ELUTE fibers.
Learn More

Nerve Regeneration

Nerve Regeneration

ELUTE fiber is driving a paradigm shift in nerve regeneration through controlled, sustained delivery of sensitive biologics including growth  factors from biomimetic three-dimensional structures.
Learn More

Tissue Engineering

new-tissueNew

Tailored for devices that require both mechanical and pharmaceutical support,  ELUTE fiber is ideal for tissue scaffolds and stents, including TissueGen’s ARCHER™ stent and drug-eluting stent for the biliary, PAD, and DVT markets.
Learn More

MedTech Breakthrough

TissueGen Wins MedTech Breakthrough Award

LEARN MORE

Upcoming Events

Recent Awards

Most-Innovative-Small-Size-Company

TissueGen has won the 2017 Future Textiles Award  for Most Innovative Small Company! Check out the video recap here

Latest News

Medical Design & Outsourcing
11 companies with interesting technology at MD&M East June 9, 2017
TissueGen Wins MedTech Breakthrough Award
TissueGen’s ELUTE® Fiber Recognized with Medical Device Engineering Breakthrough Award DALLAS, TX, June 7, 2017 – TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering, today announced that it has been selected as the winner of the...

White Paper

tissuegen-whitepaper-controlled-sustained-delivery-of-biologics-and-pharmaceuticals

Controlled Sustained Delivery of Biologics and Pharmaceuticals from ELUTE® Fiber Enabling the Future of Medicine

Click Here to Read More
2003-new-150